Opening book details…
About this Medicine article
265PSurvival of patients with aromatase inhibitors sensitive, HR+/HER2- metastatic breast cancer treated with a first-line endocrine therapy or chemotherapy in a multicenter national observational study by Jacquet, E.; Lardy-Cleaud, A.; Pistilli, B.; Cottu, P.; Delaloge, S.; Debled, M.; Vanlemmens, L.; Anne-Valérie, G.; Leheurteur, M.; Laborde, L.; Jacot, W.; Berchery, D.; Coudert, B.; Ferrero, J-M.; Parent, D.; Diéras, V.; Velten, M.; Courtinard, C.; Robain, M.; Bachelot, T. is a Medicine article available to read on EtoBox.
It is typically read by researchers, students, and practitioners in Medicine.
- Author
- Jacquet, E.; Lardy-Cleaud, A.; Pistilli, B.; Cottu, P.; Delaloge, S.; Debled, M.; Vanlemmens, L.; Anne-Valérie, G.; Leheurteur, M.; Laborde, L.; Jacot, W.; Berchery, D.; Coudert, B.; Ferrero, J-M.; Parent, D.; Diéras, V.; Velten, M.; Courtinard, C.; Robain, M.; Bachelot, T.
- Publisher
- Oxford University Press; Elsevier BV (ISSN 0923-7534)
- Published
- 2017
- Language
- EN
- Field
- Medicine (Health Sciences)